Regenerative Medicine and Stem Cells Technologies

Osteogensis imperfecta (OI) is a group of genetic disorders that mainly affect the bone. Patients with OI have bones that break easily, sometimes with no apparent cause.

The discovery, made by groups at the University of St Andrews and the University of Edinburgh, shows that “glial cells", which normally support neurons throughout the brain and spinal cord, become damaging to motor neurons in Motor Neuron Disease (MND).

Genetically engineered mouse models are often used by scientists to study how the addition, deletion or mutation of genes affects the development of disease and effects of drugs.

A research team at Nanyang Technological University, Singapore (NTU Singapore) has found an easier way to harvest healing factors—molecules that promote tissue growth and regeneration—from adult stem cells.

A team of scientists from Peter the Great St.Petersburg Polytechnic University (SPbPU) together with their colleagues developed a method of targeted drug delivery to cancer cells.

When the immune system detects a foreign pathogen, a cascade of chemical signals call white blood cells to the scene.

Celularity, the venture-backed developer of novel cell therapies for cancer treatments, has received an initial clearance from the Food and Drug Administration to begin early-stage clinical trials on a potential treatment for COVID-19

Research on immune cells "exhausted" by chronic viral infection provides clues on how to refine cancer immunotherapy. The results are scheduled for publication in Immunity.

A study led by the UPV/EHU has developed an innovative, simple treatment based on uterine stem cells to combat the Candida albicans fungus, responsible for vaginal candidiasis.

Peter Mac scientists have found a way to target acute myeloid leukemia (AML) at its source—a discovery that could yield a more effective treatment for this aggressive and often incurable blood cancer.